Abcam Future Growth
Future criteria checks 4/6
Abcam is forecast to grow earnings and revenue by 37.2% and 12.4% per annum respectively while EPS is expected to grow by 37% per annum.
Key information
37.2%
Earnings growth rate
37.0%
EPS growth rate
Biotechs earnings growth | 0% |
Revenue growth rate | 12.4% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 24 Apr 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 538 | 117 | N/A | 185 | 3 |
12/31/2024 | 482 | 76 | 104 | 141 | 7 |
12/31/2023 | 426 | 57 | 57 | 122 | 7 |
12/31/2022 | 362 | -8 | -13 | 29 | N/A |
9/30/2022 | 356 | -1 | -1 | 42 | N/A |
6/30/2022 | 350 | 7 | 12 | 55 | N/A |
3/31/2022 | 333 | 6 | 7 | 59 | N/A |
12/31/2021 | 315 | 4 | 3 | 63 | N/A |
6/30/2021 | 298 | 16 | 15 | 72 | N/A |
3/31/2021 | 284 | 7 | 14 | 65 | N/A |
12/31/2020 | 295 | 26 | 18 | 67 | N/A |
9/30/2020 | 265 | 5 | 20 | 60 | N/A |
6/30/2020 | 260 | 13 | 27 | 63 | N/A |
3/31/2020 | 267 | 27 | 31 | 67 | N/A |
12/31/2019 | 273 | 43 | 36 | 73 | N/A |
9/30/2019 | 267 | 44 | 33 | 72 | N/A |
6/30/2019 | 260 | 44 | 30 | 69 | N/A |
3/31/2019 | 253 | 51 | 25 | 69 | N/A |
12/31/2018 | 245 | 58 | 21 | 67 | N/A |
9/30/2018 | 239 | 60 | 23 | 65 | N/A |
6/30/2018 | 233 | 62 | 26 | 63 | N/A |
3/31/2018 | 230 | 59 | 35 | 64 | N/A |
12/31/2017 | 227 | 55 | 44 | 64 | N/A |
9/30/2017 | 222 | 49 | 46 | 65 | N/A |
6/30/2017 | 217 | 42 | 47 | 66 | N/A |
3/31/2017 | 206 | 41 | 45 | 64 | N/A |
12/31/2016 | 196 | 40 | 43 | 62 | N/A |
9/30/2016 | 184 | 39 | N/A | 55 | N/A |
6/30/2016 | 172 | 37 | N/A | 47 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ABCM N is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (7.5%).
Earnings vs Market: ABCM N is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ABCM N is expected to become profitable in the next 3 years.
Revenue vs Market: ABCM N's revenue (12.4% per year) is forecast to grow faster than the MX market (6.2% per year).
High Growth Revenue: ABCM N's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ABCM N's Return on Equity is forecast to be high in 3 years time